Tyra Biosciences, Inc. · NASDAQ:TYRA
BVF PARTNERS L P/IL reported a 6.10% stake in Tyra Biosciences, Inc. (Schedule 13G)
Event Sep 14, 2026 · Filed Sep 21, 2026
BVF PARTNERS L P/IL reported a 6.10% stake in Tyra Biosciences, Inc., 4,215,886 shares, as a passive investor on Sep 14, 2026. Filed Sep 21, 2026 (Schedule 13G).
- Stake
- 6.10%
- Shares
- 4,215,886
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.20% | 2,203,710 |
| BVF I GP LLC | 3.20% | 2,203,710 |
| BIOTECHNOLOGY VALUE FUND II LP | 2.40% | 1,651,007 |
| BVF II GP LLC | 2.40% | 1,651,007 |
| Biotechnology Value Trading Fund OS LP | 0.40% | 278,491 |
| BVF Partners OS Ltd. | 0.40% | 278,491 |
| BVF GP HOLDINGS LLC | 5.60% | 3,854,717 |
| BVF PARTNERS L P/IL | 6.10% | 4,215,886 |
| BVF INC/IL | 6.10% | 4,215,886 |
| LAMPERT MARK N | 6.10% | 4,215,886 |
Source
Related
- Tyra Biosciences, Inc.
- Bvf Partners L P
- Tyra Biosciences, Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Feb 17, 2026
- Schedule 13G/A · Bvf Partners L P · Feb 14, 2025
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Sep 17, 2026